Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Polyclonal Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human CHRNA3 aa 50-100.
View Alternative Names
NACHRA3, CHRNA3, Neuronal acetylcholine receptor subunit alpha-3
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody (AB183097)
immunohistochemical analysis of paraffin-embedded Human ovarian cancer tissue labeling Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 using ab183097 at dilution 1/10. Image on the right is treated with the synthetic peptide.
- WB
Supplier Data
Western blot - Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody (AB183097)
All lanes:
Western blot - Anti-Nicotinic Acetylcholine Receptor alpha 3/CHRNA3 antibody (ab183097) at 1/600 dilution
All lanes:
Hela cell at 40 µg
Secondary
All lanes:
Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution
Predicted band size: 57 kDa
false
Exposure time: 1min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CHRNA3 serves as a critical element of neurotransmission playing a part in the nicotine-induced dopaminergic signaling pathways. Often forming a complex with other subunits like beta-2 and beta-4 it modulates synaptic plasticity and influences behavioral processes such as addiction and attention. This subunit composition affects receptor specificity and sensitivity determining how neurons respond to acetylcholine and nicotine.
Pathways
The involvement of CHRNA3 in cholinergic signaling pathways is significant. It contributes to the role of nicotinic acetylcholine receptors in the addictive properties of substances like nicotine. Interaction with proteins such as CHRNB2 (nicotinic acetylcholine receptor beta-2 subunit) exemplifies how CHRNA3 participates in modulating synaptic strength and integration in the central nervous system. Its regulatory activity in these pathways demonstrates its importance in maintaining the balance of neurotransmitter systems.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Cancer medicine 12:18918-18930 PubMed37654227
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:4037 PubMed31492869
2019
Applications
Unspecified application
Species
Unspecified reactive species
FASEB bioAdvances 1:609-623 PubMed31825014
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:3805 PubMed30846819
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com